Shares in AtriCure (NSDQ:ATRC) have fallen slightly today despite the medical device maker posting fourth quarter earnings that topped expectations on Wall Street. The Mason, Ohio-based company posted losses of $3.4 million, or 9¢ per share, on sales of $52.9 million for the three months ended December 31, seeing losses grow 32.9% while sales grew 14.8% […]
AtriCure launches CryoIce CryoSphere probe
AtriCure (NSDQ:ATRC) today launched its CryoIce CryoSphere probe in the U.S. The Mason, Ohio-based company’s CryoSphere probe is designed to block pain by temporarily ablating peripheral nerves. The device features a bendable distal shaft and an ergonomic handle that enables cardiac, thoracic and general surgeons to easily target peripheral nerves. ArtiCure’s CryoSphere technology uses a freezing […]
AtriCure launches CryoIce persistent AF ablation trial
AtriCure (NSDQ:ATRC) said today that it launched a new FDA investigational device exemption cleared trial of its CryoIce system exploring its use in treating persistent atrial fibrillation during concomitant open-chested cardiac surgery. The first patient in the trial has already been treated, the Mason, Ohio-based company said. The initial procedure took place at Takoma Park, Md.’s […]
10 of the best performing medical device stocks of 2018
Updated Jan. 8, 2019 Medical device company stocks are not looking as rosy as they did two months ago, but the medtech industry still appears to be resisting the overall downward trend in stock markets, according to a Medical Design & Outsourcinganalysis. More than half of the roughly 100 largest medical device companies in the world […]
AtriCure falls despite solid Q4, 2018 prelims | Wall Street Beat
AtriCure (NSDQ:ATRC) shares took a fall today despite preliminary results for the fourth quarter and 2018 that topped estimates. The Mason, Ohio-based cardiac implant maker said it expects to post Q4 sales of $52.9 million and 2018 sales of $201.6 million, beating the consensus estimatyes on Wall Street for both periods. “We are pleased with our […]
AtriCure posts mixed bag Q3
AtriCure (NSDQ:ATRC) today posted third quarter earnings that beat Wall Street expectations for sales, but missed on loss-per-share consensus. The Mason, Ohio-based company posted losses of $7.2 million, or 22¢ per share, on sales of $49.9 million for the three months ended September 30, seeing profits drop 0.2% while sales grew 18.5% compared with the same […]
These 10 medtech companies care a lot about research
These 10 medical device companies spent the largest portion of their budgets on research and development. Here’s a look at what they produced. Each year, Medical Design & Outsourcing compiles a list of the top 100 medical device companies across the globe and ranks the companies based on annual revenue for the most recent fiscal […]
AtriCure prices $72m offering
AtriCure (NSDQ:ATRC) yesterday priced an upcoming offering, looking to raise approximately $72 million. The Mason, Ohio-based company said it will look to offer 2.5 million shares of its common stock at a price of $30.75 per share, bringing in a total of $72 million in net proceeds after discounts and expenses. The offering comes with an additional […]
AtriCure posts Street-topping Q3 prelims
AtriCure (NSDQ:ATRC) late yesterday released preliminary earnings for the third quarter that beat consensus on Wall Street. The Mason, Ohio-based company said it expects to post sales of $49.9 million, which reflects growth of approximately 18.5% over its third quarter from the previous fiscal year. US-based revenue is expected to be $39.8 million, while international sales […]
AtriCure posts Street-beating Q2, raises sales outlook
AtriCure (NSDQ:ATRC) today posted second quarter earnings that beat expectations on Wall Street and lifted its sales guidance for the remaining year. The Mason, Ohio-based company posted losses of $338,000, or 1¢ per share, on sales of $51.8 million for the three months ended June 30, seeing losses shrink 95.1% while sales grew 14.5% compared with […]
AtriCure inks multi-year Chinese distro deal with Baheal Pharma
AtriCure (NSDQ:ATRC) said today it inked a multi-year partnership deal with China’s Baheal Pharmaceutical Group to distribute AtriCure’s surgical ablation devices. Through the deal, Baheal will become Mason, Ohio-based AtriCure’s exclusive distributor in the region, replacing the company’s previous distribution partner. “At Baheal, we’re continuously looking for ways to grow and expand our business. We believe […]
- 1
- 2
- 3
- …
- 10
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube